Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.
about
Animal models of schizophrenia.Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaNew translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and ratsRepeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of ratsComparative effects of different test day challenges on performance in the 5-choice serial reaction time task.Diagnosing and managing violenceProlonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex.Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in ratsStress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor.Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity.Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task.
P2860
Q30462828-1B3D3391-0282-4DBF-8888-8AFD6700DB65Q33936354-0C77E44C-9D6B-44F9-AAD0-F610E50BF01CQ33976994-E4F8C92D-EEA0-4911-8AE4-1492C352D946Q34181201-FC101377-C61A-4F1E-9D5A-8AE14437EA22Q35024121-A775BB64-DC6D-4ADF-A4BE-C578B36B11AEQ35275505-86C5737E-031F-4FED-AA77-5F8C62F38941Q35702880-A4686733-EC80-4D52-BF52-AD253EEE9C7EQ35718134-99631910-7B7A-46EB-A8F7-0F8339C7B562Q35748684-925E3788-77DE-4344-A702-A3A0C6728AD2Q35957258-E1309FAA-8ADB-412D-AEFB-D39026102007Q36618769-E1EC6841-6B57-4D9F-B58A-8DD375DBF894Q47756805-EC1201CB-DF24-470E-BE03-E45415D617EBQ47973666-B652C6C2-F038-4A46-B332-5C75CB90BF0EQ48271960-8EEC7AA7-4DFF-4418-87BC-6D428FCE93B6Q52688732-FBFD06B8-25F2-4F5F-9E0C-CAC9132DB325
P2860
Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased impulsivity and disr ...... chronic quetiapine treatment.
@en
Increased impulsivity and disr ...... chronic quetiapine treatment.
@nl
type
label
Increased impulsivity and disr ...... chronic quetiapine treatment.
@en
Increased impulsivity and disr ...... chronic quetiapine treatment.
@nl
prefLabel
Increased impulsivity and disr ...... chronic quetiapine treatment.
@en
Increased impulsivity and disr ...... chronic quetiapine treatment.
@nl
P2860
P1476
Increased impulsivity and disr ...... chronic quetiapine treatment.
@en
P2093
Athina Markou
Nurith Amitai
P2860
P304
P356
10.1016/J.PBB.2008.08.025
P407
P577
2008-09-08T00:00:00Z